Hilary Malone
Director/Board Member chez HANSA BIOPHARMA AB
Profil
Hilary Malone is an Independent Director at Hansa Biopharma AB and the Chief Operating Officer at Valo Health LLC.
She was previously the Director at Inhibikase Therapeutics, Inc. and the Chief Operating Officer & Executive Vice President at Valo Health, Inc. She also held the position of Chief Regulatory & Compliance Officer at Reata Pharmaceuticals, Inc. and was the Chief Regulatory Officer & Senior Vice President at Sanofi, Inc. Dr. Malone received her undergraduate and doctorate degrees from the University of Dundee.
Postes actifs de Hilary Malone
| Sociétés | Poste | Début |
|---|---|---|
| HANSA BIOPHARMA AB | Director/Board Member | 12/05/2021 |
Valo Health LLC
 Valo Health LLC Packaged SoftwareTechnology Services Valo Health LLC operates as a drug discovery technology company. It offers cloud computing as well as longitudinal and human data to create an entirely new drug discovery and development process. The company was founded in 2019 and is headquartered in Boston, MA. | Chief Operating Officer | 01/01/2020 |
Anciens postes connus de Hilary Malone
| Sociétés | Poste | Fin |
|---|---|---|
Valo Health, Inc.
 Valo Health, Inc. Financial ConglomeratesFinance Part of Valo Health LLC, Valo Health, Inc. operates as a development stage company. The private company is based in Boston, MA. The company was founded by David A. Berry. David A. Berry has been the CEO since incorporation. | Chief Operating Officer | 01/09/2021 |
| INHIBIKASE THERAPEUTICS, INC. | Director/Board Member | 01/01/2019 |
Sanofi, Inc.
 Sanofi, Inc. Drugstore ChainsRetail Trade Part of Abbott Laboratories, Sanofi, Inc. is a private company based in New York, NY. | Corporate Officer/Principal | - |
| REATA PHARMACEUTICALS, INC. | General Counsel | - |
Formation de Hilary Malone
| University Of Dundee | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| HANSA BIOPHARMA AB | Health Technology |
| INHIBIKASE THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Valo Health, Inc.
Valo Health, Inc. Financial ConglomeratesFinance Part of Valo Health LLC, Valo Health, Inc. operates as a development stage company. The private company is based in Boston, MA. The company was founded by David A. Berry. David A. Berry has been the CEO since incorporation. | Finance |
Reata Pharmaceuticals, Inc.
 Reata Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation. The company was founded by J. Warren Huff in 2002 and is headquartered in Plano, TX. | Health Technology |
Sanofi, Inc.
Sanofi, Inc. Drugstore ChainsRetail Trade Part of Abbott Laboratories, Sanofi, Inc. is a private company based in New York, NY. | Retail Trade |
Valo Health LLC
Valo Health LLC Packaged SoftwareTechnology Services Valo Health LLC operates as a drug discovery technology company. It offers cloud computing as well as longitudinal and human data to create an entirely new drug discovery and development process. The company was founded in 2019 and is headquartered in Boston, MA. | Technology Services |
